カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の水痘ワクチン接種市場予測2023-2029：一価ワクチン、混合ワクチン

【英語タイトル】Varicella Vaccination Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8736）・商品コード：MMG23LY8736
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：71
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の水痘ワクチン接種市場規模と予測を収録しています。・世界の水痘ワクチン接種市場：売上、2018年-2023年、2024年-2029年
・世界の水痘ワクチン接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の水痘ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一価ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

水痘ワクチン接種のグローバル主要企業は、Merck、 BCHT、 Shanghai Institute、 GSK、 Keygen、 Green Cross、 Biken、 Shanghai Rongsheng Biotech、 Changshengなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、水痘ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の水痘ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年
世界の水痘ワクチン接種市場：タイプ別市場シェア、2022年
・一価ワクチン、混合ワクチン

世界の水痘ワクチン接種市場：用途別、2018年-2023年、2024年-2029年
世界の水痘ワクチン接種市場：用途別市場シェア、2022年
・子供、大人

世界の水痘ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年
世界の水痘ワクチン接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における水痘ワクチン接種のグローバル売上、2018年-2023年
・主要企業における水痘ワクチン接種のグローバル売上シェア、2022年
・主要企業における水痘ワクチン接種のグローバル販売量、2018年-2023年
・主要企業における水痘ワクチン接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、 BCHT、 Shanghai Institute、 GSK、 Keygen、 Green Cross、 Biken、 Shanghai Rongsheng Biotech、 Changsheng

*************************************************************

・調査・分析レポートの概要
水痘ワクチン接種市場の定義
市場セグメント
世界の水痘ワクチン接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の水痘ワクチン接種市場規模
世界の水痘ワクチン接種市場規模：2022年 VS 2029年
世界の水痘ワクチン接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの水痘ワクチン接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の水痘ワクチン接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：一価ワクチン、混合ワクチン
水痘ワクチン接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子供、大人
水痘ワクチン接種の用途別グローバル売上・予測

・地域別市場分析
地域別水痘ワクチン接種市場規模 2022年と2029年
地域別水痘ワクチン接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 BCHT、 Shanghai Institute、 GSK、 Keygen、 Green Cross、 Biken、 Shanghai Rongsheng Biotech、 Changsheng
...

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccination. This report contains market size and forecasts of Varicella Vaccination in global, including the following market information:
Global Varicella Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Varicella Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Varicella Vaccination companies in 2022 (%)
The global Varicella Vaccination market was valued at US$ 4294.8 million in 2022 and is projected to reach US$ 7108.9 million by 2029, at a CAGR of 7.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Varicella Vaccination Market Segment Percentages, by Type, 2022 (%)
Monovalent Vaccine
Combination Vaccine
Global Varicella Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Varicella Vaccination Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Global Varicella Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Varicella Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Varicella Vaccination revenues share in global market, 2022 (%)
Key companies Varicella Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Varicella Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BCHT
Shanghai Institute
GSK
Keygen
Green Cross
Biken
Shanghai Rongsheng Biotech
Changsheng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Varicella Vaccination, market overview.
Chapter 2: Global Varicella Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Varicella Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Varicella Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Varicella Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Varicella Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Varicella Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Varicella Vaccination Overall Market Size
2.1 Global Varicella Vaccination Market Size: 2022 VS 2029
2.2 Global Varicella Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Varicella Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Varicella Vaccination Players in Global Market
3.2 Top Global Varicella Vaccination Companies Ranked by Revenue
3.3 Global Varicella Vaccination Revenue by Companies
3.4 Global Varicella Vaccination Sales by Companies
3.5 Global Varicella Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Varicella Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Varicella Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Varicella Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Varicella Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Varicella Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Varicella Vaccination Market Size Markets, 2022 & 2029
4.1.2 Monovalent Vaccine
4.1.3 Combination Vaccine
4.2 By Type – Global Varicella Vaccination Revenue & Forecasts
4.2.1 By Type – Global Varicella Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Varicella Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Varicella Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Varicella Vaccination Sales & Forecasts
4.3.1 By Type – Global Varicella Vaccination Sales, 2018-2023
4.3.2 By Type – Global Varicella Vaccination Sales, 2024-2029
4.3.3 By Type – Global Varicella Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Varicella Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Varicella Vaccination Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adults
5.2 By Application – Global Varicella Vaccination Revenue & Forecasts
5.2.1 By Application – Global Varicella Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Varicella Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Varicella Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Varicella Vaccination Sales & Forecasts
5.3.1 By Application – Global Varicella Vaccination Sales, 2018-2023
5.3.2 By Application – Global Varicella Vaccination Sales, 2024-2029
5.3.3 By Application – Global Varicella Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Varicella Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Varicella Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Varicella Vaccination Revenue & Forecasts
6.2.1 By Region – Global Varicella Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Varicella Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Varicella Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Varicella Vaccination Sales & Forecasts
6.3.1 By Region – Global Varicella Vaccination Sales, 2018-2023
6.3.2 By Region – Global Varicella Vaccination Sales, 2024-2029
6.3.3 By Region – Global Varicella Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Varicella Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Varicella Vaccination Sales, 2018-2029
6.4.3 US Varicella Vaccination Market Size, 2018-2029
6.4.4 Canada Varicella Vaccination Market Size, 2018-2029
6.4.5 Mexico Varicella Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Varicella Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Varicella Vaccination Sales, 2018-2029
6.5.3 Germany Varicella Vaccination Market Size, 2018-2029
6.5.4 France Varicella Vaccination Market Size, 2018-2029
6.5.5 U.K. Varicella Vaccination Market Size, 2018-2029
6.5.6 Italy Varicella Vaccination Market Size, 2018-2029
6.5.7 Russia Varicella Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Varicella Vaccination Market Size, 2018-2029
6.5.9 Benelux Varicella Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Varicella Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Varicella Vaccination Sales, 2018-2029
6.6.3 China Varicella Vaccination Market Size, 2018-2029
6.6.4 Japan Varicella Vaccination Market Size, 2018-2029
6.6.5 South Korea Varicella Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Varicella Vaccination Market Size, 2018-2029
6.6.7 India Varicella Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Varicella Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Varicella Vaccination Sales, 2018-2029
6.7.3 Brazil Varicella Vaccination Market Size, 2018-2029
6.7.4 Argentina Varicella Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Varicella Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Varicella Vaccination Sales, 2018-2029
6.8.3 Turkey Varicella Vaccination Market Size, 2018-2029
6.8.4 Israel Varicella Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Varicella Vaccination Market Size, 2018-2029
6.8.6 UAE Varicella Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Varicella Vaccination Major Product Offerings
7.1.4 Merck Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 BCHT
7.2.1 BCHT Company Summary
7.2.2 BCHT Business Overview
7.2.3 BCHT Varicella Vaccination Major Product Offerings
7.2.4 BCHT Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 BCHT Key News & Latest Developments
7.3 Shanghai Institute
7.3.1 Shanghai Institute Company Summary
7.3.2 Shanghai Institute Business Overview
7.3.3 Shanghai Institute Varicella Vaccination Major Product Offerings
7.3.4 Shanghai Institute Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Shanghai Institute Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Varicella Vaccination Major Product Offerings
7.4.4 GSK Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Keygen
7.5.1 Keygen Company Summary
7.5.2 Keygen Business Overview
7.5.3 Keygen Varicella Vaccination Major Product Offerings
7.5.4 Keygen Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Keygen Key News & Latest Developments
7.6 Green Cross
7.6.1 Green Cross Company Summary
7.6.2 Green Cross Business Overview
7.6.3 Green Cross Varicella Vaccination Major Product Offerings
7.6.4 Green Cross Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Green Cross Key News & Latest Developments
7.7 Biken
7.7.1 Biken Company Summary
7.7.2 Biken Business Overview
7.7.3 Biken Varicella Vaccination Major Product Offerings
7.7.4 Biken Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 Biken Key News & Latest Developments
7.8 Shanghai Rongsheng Biotech
7.8.1 Shanghai Rongsheng Biotech Company Summary
7.8.2 Shanghai Rongsheng Biotech Business Overview
7.8.3 Shanghai Rongsheng Biotech Varicella Vaccination Major Product Offerings
7.8.4 Shanghai Rongsheng Biotech Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 Shanghai Rongsheng Biotech Key News & Latest Developments
7.9 Changsheng
7.9.1 Changsheng Company Summary
7.9.2 Changsheng Business Overview
7.9.3 Changsheng Varicella Vaccination Major Product Offerings
7.9.4 Changsheng Varicella Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 Changsheng Key News & Latest Developments
8 Global Varicella Vaccination Production Capacity, Analysis
8.1 Global Varicella Vaccination Production Capacity, 2018-2029
8.2 Varicella Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Varicella Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Varicella Vaccination Supply Chain Analysis
10.1 Varicella Vaccination Industry Value Chain
10.2 Varicella Vaccination Upstream Market
10.3 Varicella Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Varicella Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Varicella Vaccination in Global Market
Table 2. Top Varicella Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Varicella Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Varicella Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Varicella Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Varicella Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Varicella Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Varicella Vaccination Product Type
Table 9. List of Global Tier 1 Varicella Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Varicella Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Varicella Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Varicella Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Varicella Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Varicella Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Varicella Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Varicella Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Varicella Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Varicella Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Varicella Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Varicella Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Varicella Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Varicella Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Varicella Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Varicella Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Varicella Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Varicella Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Varicella Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Varicella Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Varicella Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Varicella Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Varicella Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Varicella Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Varicella Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Varicella Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Varicella Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Varicella Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Varicella Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Varicella Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Varicella Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Varicella Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Varicella Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Varicella Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Varicella Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Varicella Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Varicella Vaccination Sales, (Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Varicella Vaccination Product Offerings
Table 48. Merck Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. BCHT Company Summary
Table 51. BCHT Varicella Vaccination Product Offerings
Table 52. BCHT Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. BCHT Key News & Latest Developments
Table 54. Shanghai Institute Company Summary
Table 55. Shanghai Institute Varicella Vaccination Product Offerings
Table 56. Shanghai Institute Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Shanghai Institute Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK Varicella Vaccination Product Offerings
Table 60. GSK Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GSK Key News & Latest Developments
Table 62. Keygen Company Summary
Table 63. Keygen Varicella Vaccination Product Offerings
Table 64. Keygen Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Keygen Key News & Latest Developments
Table 66. Green Cross Company Summary
Table 67. Green Cross Varicella Vaccination Product Offerings
Table 68. Green Cross Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Green Cross Key News & Latest Developments
Table 70. Biken Company Summary
Table 71. Biken Varicella Vaccination Product Offerings
Table 72. Biken Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Biken Key News & Latest Developments
Table 74. Shanghai Rongsheng Biotech Company Summary
Table 75. Shanghai Rongsheng Biotech Varicella Vaccination Product Offerings
Table 76. Shanghai Rongsheng Biotech Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Shanghai Rongsheng Biotech Key News & Latest Developments
Table 78. Changsheng Company Summary
Table 79. Changsheng Varicella Vaccination Product Offerings
Table 80. Changsheng Varicella Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Changsheng Key News & Latest Developments
Table 82. Varicella Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 83. Global Varicella Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Varicella Vaccination Production by Region, 2018-2023 (Units)
Table 85. Global Varicella Vaccination Production by Region, 2024-2029 (Units)
Table 86. Varicella Vaccination Market Opportunities & Trends in Global Market
Table 87. Varicella Vaccination Market Drivers in Global Market
Table 88. Varicella Vaccination Market Restraints in Global Market
Table 89. Varicella Vaccination Raw Materials
Table 90. Varicella Vaccination Raw Materials Suppliers in Global Market
Table 91. Typical Varicella Vaccination Downstream
Table 92. Varicella Vaccination Downstream Clients in Global Market
Table 93. Varicella Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Varicella Vaccination Segment by Type in 2022
Figure 2. Varicella Vaccination Segment by Application in 2022
Figure 3. Global Varicella Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Varicella Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Varicella Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Varicella Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Varicella Vaccination Revenue in 2022
Figure 9. By Type - Global Varicella Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Varicella Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Varicella Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Varicella Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Varicella Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Varicella Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Varicella Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Varicella Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Varicella Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Varicella Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Varicella Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Varicella Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Varicella Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Varicella Vaccination Sales Market Share, 2018-2029
Figure 23. US Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Varicella Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Varicella Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Varicella Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Varicella Vaccination Sales Market Share, 2018-2029
Figure 37. China Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Varicella Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Varicella Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Varicella Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Varicella Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Varicella Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Varicella Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Varicella Vaccination by Region, 2022 VS 2029
Figure 54. Varicella Vaccination Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の水痘ワクチン接種市場予測2023-2029：一価ワクチン、混合ワクチン] (コード：MMG23LY8736)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の水痘ワクチン接種市場予測2023-2029：一価ワクチン、混合ワクチン]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の弱毒水痘生ワクチン接種市場予測2023-2029：一価ワクチン、混合ワクチン
  • 麻疹/風疹ワクチンのグローバル市場2023年：一価ワクチン、多価ワクチン
  • 世界の水痘ウイルス生ワクチン市場予測2023-2029：子供、大人
  • 世界の黄熱病予防接種市場予測2023-2029：定期予防接種、旅行者、その他
  • 世界のヒト用ワクチン接種市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆